Nuritas, a start-up using artificial intelligence that is reinventing therapeutics discovery, announced a $3.2 million financing, the highest initial investment ever raised by an Irish company operating in this space. The round was led by Singapore-based New Protein Capital, a food and agro-tech investment firm, which brought together financial supporters from three continents, including Silicon Valley investor Ali Partovi.
Using a platform that combines artificial intelligence and DNA sequencing, Nuritas discovers particular molecules – called peptides – in natural sources such as food that have scientifically validated health benefits. The company is able to find and unlock these life-changing peptides ten times faster than the prohibitive norm and at a fraction of the cost, thus establishing Nuritas as a game-changer within the health and wellness industry. Nuritas has already developed and patented health-improving ingredients that can address global challenges as broad as inflammation, diabetes, ageing and MRSA.
“I was told this was impossible and I decided not to listen,” said Nuritas founder Dr Nora Khaldi. “I built a team who believe in what we do and together we made it happen. We have discovered and patented some incredible life-changing ingredients and we will discover many more.”
For more on Nuritas listen to TechRadio’s special report from the ITLG Summit.
TechCentral Reporters
Subscribers 0
Fans 0
Followers 0
Followers